CTFA guidelines
This article was originally published in The Rose Sheet
Executive Summary
The Cosmetic, Toiletry and Fragrance Association is requesting public comments on two new and one revised Safety Evaluation Guidelines by July 8, CTFA announces. The two new guidelines for genotoxicity and reproductive and developmental toxicity testing describe both in vivo and in vitro models, while the revised guidelines on photoirritation/photoallergy include in vivo, in vitro and clinical test methods, association notes. CTFA Safety Evaluation Guidelines "provide manufacturers with guidance regarding the use of preclinical and clinical safety testing as means to substantiate the safety of both ingredients and finished cosmetic products"...
You may also be interested in...
CTFA guidelines
The Cosmetic, Toiletry and Fragrance Association is requesting comments on a new Safety Evaluation Guideline on in vitro test methods for evaluating skin absorption; comments are due by Sept. 25. The association's guidelines "provide manufacturers with guidance regarding the use of preclinical and clinical safety testing as a means to substantiate the safety of both ingredients and finished cosmetic products." In June, CTFA requested comments on two new guidelines for genotoxicity and reproductive and developmental toxicity testing as well as revised guidelines on photoirritation/photoallergy (1"The Rose Sheet" June 26, 2006, In Brief)...
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.